Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2025-03-20 Sale |
2025-03-20 5:21 pm |
Climb Bio Inc. | CLYM | Pimblett Emily SVP, Finance & CAO |
1,199 | $1.31 | $1,571 | 35,130 (Direct) |
View |
2024-12-19 Sale |
2024-12-20 4:15 pm |
Climb Bio Inc. | CLYM | Pimblett Emily CHIEF ACCOUNTING OFFICER |
1,235 | $2.02 | $2,495 | 36,329 (Direct) |
View |
2024-09-20 Sale |
2024-09-20 9:53 pm |
Eliem Therapeutics Inc. | ELYM | Pimblett Emily CHIEF ACCOUNTING OFFICER |
1,191 | $8.1791 | $9,741 | 37,564 (Direct) |
View |
2024-06-20 Sale |
2024-06-21 2:57 pm |
Eliem Therapeutics Inc. | ELYM | Pimblett Emily CHIEF ACCOUNTING OFFICER |
1,245 | $7.2145 | $8,982 | 38,755 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2025-03-18 Exercise |
2025-03-20 5:21 pm |
N/A N/A |
Climb Bio Inc. | CLYM | Pimblett Emily SVP, Finance & CAO |
5,000 | $0 | 35,130 (Direct) |
View |
2025-01-13 Option Award |
2025-01-15 4:15 pm |
N/A 2035-01-12 |
Climb Bio Inc. | CLYM | Pimblett Emily SVP, Finance and CAO |
100,000 | $0 | 100,000 (Direct) |
View |
2024-12-18 Exercise |
2024-12-20 4:15 pm |
N/A N/A |
Climb Bio Inc. | CLYM | Pimblett Emily CHIEF ACCOUNTING OFFICER |
5,000 | $0 | 36,329 (Direct) |
View |
2024-09-18 Exercise |
2024-09-20 9:53 pm |
N/A N/A |
Eliem Therapeutics Inc. | ELYM | Pimblett Emily CHIEF ACCOUNTING OFFICER |
5,000 | $0 | 37,564 (Direct) |
View |
2024-06-18 Exercise |
2024-06-21 2:57 pm |
N/A N/A |
Eliem Therapeutics Inc. | ELYM | Pimblett Emily CHIEF ACCOUNTING OFFICER |
5,000 | $0 | 38,755 (Direct) |
View |
2024-03-18 Exercise |
2024-03-20 4:33 pm |
N/A N/A |
Eliem Therapeutics Inc. | ELYM | Pimblett Emily CHIEF ACCOUNTING OFFICER |
40,000 | $0 | 40,000 (Direct) |
View |
Ownership |
2023-03-21 10:21 am |
N/A 2031-04-26 |
Eliem Therapeutics Inc. | ELYM | Pimblett Emily Chief Accounting Officer |
0 | $0 | 95,000 (Direct) |
View |